{"Title": ["Billionaire Ken Griffin Pulls the Trigger on These 3 Penny Stocks", "Health Care Sector Update for 05/14/2020: IMUX,AXLA, MEIP, XLV, VHT, IYH, IBB", "BUZZ-U.S. STOCKS ON THE MOVE-Wall St banks, U.S. airlines, casinos, Tesla, J&J, Apple, Roku", "BUZZ-U.S. STOCKS ON THE MOVE-U.S. airlines, banks, General Electric, Tesla, J&J", "BUZZ-U.S. STOCKS ON THE MOVE-J&J, Apple, Roku, Tesla, U.S. airlines", "MEI Pharma (MEIP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "MEI Pharma Sees Hammer Chart Pattern: Time to Buy?", "Will MEI Pharma (MEIP) Report Negative Earnings Next Week? What You Should Know", "Billionaire Ken Griffin Pulls the Trigger on These 3 Penny Stocks", "Should You Buy MEI Pharma (MEIP) Ahead of Earnings?", "Mid-Afternoon Market Update: Dow Rises Over 200 Points; Ambarella Shares Slide On Weak Sales Forecast", "Health Care Sector Update for 01/11/2018: JNJ, PFE, ABT, MRK, AMGN, ARDM, MEIP, BSX, CRL, CRZ.CN, AQS.V", "Health Care Sector Update for 01/11/2018: MDXG, ENDP, MEIP, BSX, CRL", "Health Care Sector Update for 01/11/2018: ENDP,MEIP,BSX,CRL", "Paratek Pharmaceuticals Set To Explode As The Holy Grail Of Antibiotics Omadacycline Nears FDA Approval", "Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher", "After-Hours Earnings Report for August 30, 2018 : LULU, ULTA, COO, NTNX, YEXT, AMBA, AOBC, ATEN, MEIP", "Galectin Therapeutics (GALT) in Focus: Stock Moves 6.5% Higher", "Dermira, Inc. (DERM) Soars: Stock Adds 5.3% in Session", "AcelRx Pharmaceuticals (ACRX) in Focus: Stock Moves 19.6% Higher", "PTC Therapeutics, Inc. (PTCT) in Focus: Stock Moves 14.6% Higher", "GlycoMimetics (GLYC) in Focus: Stock Moves 9.2% Higher", "Zogenix, Inc. (ZGNX) Jumps: Stock Rises 5.2%", "MEI Pharma-Presage Biosciences on License Deal for Voruciclib", "Corbus Pharmaceuticals (CRBP) in Focus: Stock Moves 10% Higher", "MEI Pharma (MEIP) Worth a Look: Stock Rises 12% in Session", "BioMarin Files BLA for Phenylketonuria Candidate Pegvaliase", "Concordia International (CXRX) Catches Eye: Stock Jumps 9.9%", "Valeant's (VRX) NDA for Bowel Cleansing Drug Accepted by FDA", "KemPharm (KMPH) Strengthens its ADHD Prodrug Pipeline", "Why is Catalyst Pharmaceuticals' Stock Up 160% this Year?", "Seattle Genetics (SGEN) Reports Positive Data for Adcetris", "Pre-Market Earnings Report for September 5, 2017 : DLNG, MEIP", "Indivor's Opioid Use Disorder Drug Meets Primary Endpoint", "Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug", "Horizon Pharma Gets Health Canada Approval for Procysbi", "Rigel Pharmaceuticals' NDA for Tavalisse Accepted by FDA", "Seattle Genetics Halts Phase III Study on Leukemia Drug", "Celgene Presents Interim Results from Cancer Drug Study", "Omeros (OMER) Hits New 52-Week High on Positive FDA Decision", "Shire (SHPG) Receives MAA Validation for Veyvondi by EMA", "Omeros (OMER) Lead Candidate Gets Breakthrough Designation", "Novo Nordisk (NVO) Presents Data for Type II Diabetes Drug", "Seres Therapeutics' Stock Up as SER-109 Moves to Phase III", "Intercept (ICPT) Releases Data from Phase II Flint Trial", "Alkermes Commences Phase III Study for Schizophrenia Drug", "Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M", "Endo Asked to Withdraw Pain Drug-Opana ER by FDA, Stock Down", "Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study", "Alkermes Gets FDA Nod for Two Month Dose of Aristada", "Seattle Genetics Reports Updated Results on Cancer Drug", "Kite Pharma (KITE) Releases Data on Lead Drug for Leukemia", "Radius (RDUS) Announces Positive Data on Breast Cancer Drug", "Alnylam's Givosiran Gets Breakthrough Therapy Status by FDA", "Novo Nordisk's (NVO) Drug Gets FDA Approval for Hemophilia B", "Health Care Sector Update for 05/31/2017: MEIP", "Mallinckrodt (MNK) Commences Phase III Study of StrataGraft", "4 Reasons Why You Should Add Bayer Stock to Your Portfolio", "MEI Pharma (MEIP) Shows Strength: Stock Moves 7.6% Higher", "Bristol-Myers' Opdivo Gets Priority Review for Liver Cancer", "Achaogen's Plazomicin Gets Breakthrough Therapy Designation", "Catalyst Pharmaceuticals Focuses on Development of Firdapse", "Calithera Biosciences (CALA) Jumps: Stock Moves 17% Higher", "Vertex Ups Kalydeco Sales View as FDA Okays Label Expansion", "Ligand (LGND) Signs Licensing Deal with xCella Biosciences", "Reasons to Add Puma Biotechnology (PBYI) to Portfolio Now", "Alexion's (ALXN) Strensiq Results Positive in Long-Term Study", "Minerva (NERV) Provides Phase III Development Strategy for MIN-101", "Ionis (IONS) Stock Falls Despite Positive Inotersen Data", "MEI Pharma (MEIP) Looks Good: Stock Adds 5.7% in Session", "Health Care Sector Update for 08/08/2016: FATE,MEIP,CHEK", "Health Care Sector Update for 08/08/2016: PTI,MEIP,CHEK", "Kamada (KMDA) Posts Q1 Loss Wider than Expected, Sales Miss", "Reasons to Add Puma Biotechnology (PBYI) to Portfolio Now", "Alexion's (ALXN) Strensiq Results Positive in Long-Term Study", "Minerva (NERV) Provides Phase III Development Strategy for MIN-101", "Ionis (IONS) Stock Falls Despite Positive Inotersen Data", "Will Edwards Lifesciences (EW) Top Q1 Earnings Estimates? - Analyst Blog", "Can The Uptrend Continue for MEI Pharma (MEIP)? - Tale of the Tape", "Will Mead Johnson's (MJN) Q1 Earnings Surprise Estimates? - Analyst Blog", "MEI Pharma (MEIP) in Focus: Stock Rises 7.9% in Session", "Will CONMED (CNMD) Disappoint Earnings Estimates in Q1? - Analyst Blog", "Will Intuitive Surgical (ISRG) Surprise Earnings in Q1? - Analyst Blog", "Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog", "MEI Pharma (MEIP) Is in Oversold Territory: What's Next? - Tale of the Tape", "Monday Sector Laggards: Railroads, Drugs", "Friday 1/23 Insider Buying Report: CPRX, MEIP", "Health Care Sector Update for 12/23/2014: ACHN, MEIP, ABBV", "ResMed (RMD) Poised to Outshine Q3 Earnings Estimates - Analyst Blog", "Sector Update: Healthcare Stocks Mixed; MEI Pharma Climbing After New Leukemia Drug Produces Strong Response in Early Testing", "Sector Update: Healthcare", "Moving Average Crossover Alert: MEI Pharma (MEIP) - Tale of the Tape", "MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape", "MEI Pharma (MEIP) is Overbought, What's Next? - Tale of the Tape", "MEI Pharma Boosts Oncology Pipeline - Analyst Blog", "Topline Data on Astex Candidate - Analyst Blog", "Health Care Sector Update for 12/12/2014: SNY, MEIP, ONTY"], "Elapsed Time": ["JUN 16, 2020", "MAY 14, 2020", "APR 14, 2020", "APR 14, 2020", "APR 14, 2020", "FEB 7, 2019", "NOV 12, 2018", "NOV 7, 2018", "JUN 16, 2020", "AUG 29, 2018", "JUN 6, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "DEC 12, 2017", "OCT 31, 2017", "AUG 30, 2018", "OCT 11, 2017", "OCT 11, 2017", "OCT 3, 2017", "OCT 2, 2017", "SEP 26, 2017", "SEP 11, 2017", "SEP 6, 2017", "OCT 20, 2017", "JUL 7, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUN 29, 2017", "JUN 29, 2017", "JUN 28, 2017", "JUN 27, 2017", "SEP 1, 2017", "JUN 22, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 19, 2017", "JUN 16, 2017", "JUN 22, 2017", "JUN 14, 2017", "JUN 14, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 12, 2017", "JUN 12, 2017", "JUN 9, 2017", "JUN 16, 2017", "JUN 7, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 1, 2017", "JUN 1, 2017", "MAY 31, 2017", "JUN 8, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 25, 2017", "MAY 24, 2017", "MAY 23, 2017", "MAY 22, 2017", "MAY 18, 2017", "MAY 31, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 16, 2017", "OCT 4, 2016", "AUG 8, 2016", "AUG 8, 2016", "MAY 17, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 16, 2017", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 12, 2016", "APR 20, 2015", "APR 17, 2015", "APR 17, 2015", "APR 2, 2015", "MAR 23, 2015", "JAN 23, 2015", "DEC 23, 2014", "APR 21, 2015", "JUN 10, 2014", "JUN 10, 2014", "JUN 2, 2014", "MAR 28, 2014", "MAR 6, 2014", "SEP 11, 2013", "AUG 29, 2013", "DEC 12, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/billionaire-ken-griffin-pulls-the-trigger-on-these-3-penny-stocks-2020-06-16", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-14-2020%3A-imuxaxla-meip-xlv-vht-iyh-ibb-2020-05-14", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-wall-st-banks-u.s.-airlines-casinos-tesla-jj-apple-roku-2020", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-u.s.-airlines-banks-general-electric-tesla-jj-2020-04-14", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-jj-apple-roku-tesla-u.s.-airlines-2020-04-14", "https://www.nasdaq.com/articles/mei-pharma-meip-may-report-negative-earnings%3A-know-the-trend-ahead-of-next-weeks-release", "https://www.nasdaq.com/articles/mei-pharma-sees-hammer-chart-pattern%3A-time-to-buy-2018-11-12", "https://www.nasdaq.com/articles/will-mei-pharma-meip-report-negative-earnings-next-week-what-you-should-know-2018-11-07", "https://www.nasdaq.com/articles/billionaire-ken-griffin-pulls-the-trigger-on-these-3-penny-stocks-2020-06-16", "https://www.nasdaq.com/articles/should-you-buy-mei-pharma-meip-ahead-of-earnings-2018-08-29", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-rises-over-200-points-ambarella-shares-slide-weak-sales", "https://www.nasdaq.com/articles/health-care-sector-update-01112018-jnj-pfe-abt-mrk-amgn-ardm-meip-bsx-crl-crzcn-aqsv-2018", "https://www.nasdaq.com/articles/health-care-sector-update-01112018-mdxg-endp-meip-bsx-crl-2018-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-01112018-endpmeipbsxcrl-2018-01-11", "https://www.nasdaq.com/articles/paratek-pharmaceuticals-set-explode-holy-grail-antibiotics-omadacycline-nears-fda-approval", "https://www.nasdaq.com/articles/advanced-accelerator-aaap-in-focus%3A-stock-moves-10.4-higher-2017-10-31", "https://www.nasdaq.com/articles/after-hours-earnings-report-august-30-2018-lulu-ulta-coo-ntnx-yext-amba-aobc-aten-meip", "https://www.nasdaq.com/articles/galectin-therapeutics-galt-in-focus%3A-stock-moves-6.5-higher-2017-10-11", "https://www.nasdaq.com/articles/dermira-inc.-derm-soars%3A-stock-adds-5.3-in-session-2017-10-11", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-in-focus%3A-stock-moves-19.6-higher-2017-10-03", "https://www.nasdaq.com/articles/ptc-therapeutics-inc.-ptct-in-focus%3A-stock-moves-14.6-higher-2017-10-02", "https://www.nasdaq.com/articles/glycomimetics-glyc-in-focus%3A-stock-moves-9.2-higher-2017-09-26", "https://www.nasdaq.com/articles/zogenix-inc.-zgnx-jumps%3A-stock-rises-5.2-2017-09-11", "https://www.nasdaq.com/articles/mei-pharma-presage-biosciences-on-license-deal-for-voruciclib-2017-09-06", "https://www.nasdaq.com/articles/corbus-pharmaceuticals-crbp-in-focus%3A-stock-moves-10-higher-2017-10-20", "https://www.nasdaq.com/articles/mei-pharma-meip-worth-a-look%3A-stock-rises-12-in-session-2017-07-07", "https://www.nasdaq.com/articles/biomarin-files-bla-for-phenylketonuria-candidate-pegvaliase-2017-07-03", "https://www.nasdaq.com/articles/concordia-international-cxrx-catches-eye%3A-stock-jumps-9.9-2017-07-03", "https://www.nasdaq.com/articles/valeants-vrx-nda-for-bowel-cleansing-drug-accepted-by-fda-2017-06-29", "https://www.nasdaq.com/articles/kempharm-kmph-strengthens-its-adhd-prodrug-pipeline-2017-06-29", "https://www.nasdaq.com/articles/why-is-catalyst-pharmaceuticals-stock-up-160-this-year-2017-06-28", "https://www.nasdaq.com/articles/seattle-genetics-sgen-reports-positive-data-for-adcetris-2017-06-27", "https://www.nasdaq.com/articles/pre-market-earnings-report-september-5-2017-dlng-meip-2017-09-01", "https://www.nasdaq.com/articles/indivors-opioid-use-disorder-drug-meets-primary-endpoint-2017-06-22", "https://www.nasdaq.com/articles/seattle-genetics-sgen-submits-bla-to-fda-for-cancer-drug-2017-06-21", "https://www.nasdaq.com/articles/horizon-pharma-gets-health-canada-approval-for-procysbi-2017-06-20", "https://www.nasdaq.com/articles/rigel-pharmaceuticals-nda-for-tavalisse-accepted-by-fda-2017-06-20", "https://www.nasdaq.com/articles/seattle-genetics-halts-phase-iii-study-on-leukemia-drug-2017-06-20", "https://www.nasdaq.com/articles/celgene-presents-interim-results-from-cancer-drug-study-2017-06-19", "https://www.nasdaq.com/articles/omeros-omer-hits-new-52-week-high-on-positive-fda-decision-2017-06-16", "https://www.nasdaq.com/articles/shire-shpg-receives-maa-validation-for-veyvondi-by-ema-2017-06-22", "https://www.nasdaq.com/articles/omeros-omer-lead-candidate-gets-breakthrough-designation-2017-06-14", "https://www.nasdaq.com/articles/novo-nordisk-nvo-presents-data-for-type-ii-diabetes-drug-2017-06-14", "https://www.nasdaq.com/articles/seres-therapeutics-stock-up-as-ser-109-moves-to-phase-iii-2017-06-13", "https://www.nasdaq.com/articles/intercept-icpt-releases-data-from-phase-ii-flint-trial-2017-06-13", "https://www.nasdaq.com/articles/alkermes-commences-phase-iii-study-for-schizophrenia-drug-2017-06-12", "https://www.nasdaq.com/articles/valeant-inks-deal-to-divest-inova-pharmaceuticals-for-%24930m-2017-06-12", "https://www.nasdaq.com/articles/endo-asked-to-withdraw-pain-drug-opana-er-by-fda-stock-down-2017-06-09", "https://www.nasdaq.com/articles/mallinckrodt-initiates-amyotrophic-lateral-sclerosis-study-2017-06-16", "https://www.nasdaq.com/articles/alkermes-gets-fda-nod-for-two-month-dose-of-aristada-2017-06-07", "https://www.nasdaq.com/articles/seattle-genetics-reports-updated-results-on-cancer-drug-2017-06-06", "https://www.nasdaq.com/articles/kite-pharma-kite-releases-data-on-lead-drug-for-leukemia-2017-06-06", "https://www.nasdaq.com/articles/radius-rdus-announces-positive-data-on-breast-cancer-drug-2017-06-05", "https://www.nasdaq.com/articles/alnylams-givosiran-gets-breakthrough-therapy-status-by-fda-2017-06-01", "https://www.nasdaq.com/articles/novo-nordisks-nvo-drug-gets-fda-approval-for-hemophilia-b-2017-06-01", "https://www.nasdaq.com/articles/health-care-sector-update-05312017-meip-2017-05-31", "https://www.nasdaq.com/articles/mallinckrodt-mnk-commences-phase-iii-study-of-stratagraft-2017-06-08", "https://www.nasdaq.com/articles/4-reasons-why-you-should-add-bayer-stock-to-your-portfolio-2017-05-30", "https://www.nasdaq.com/articles/mei-pharma-meip-shows-strength%3A-stock-moves-7.6-higher-2017-05-30", "https://www.nasdaq.com/articles/bristol-myers-opdivo-gets-priority-review-for-liver-cancer-2017-05-25", "https://www.nasdaq.com/articles/achaogens-plazomicin-gets-breakthrough-therapy-designation-2017-05-24", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-focuses-on-development-of-firdapse-2017-05-23", "https://www.nasdaq.com/articles/calithera-biosciences-cala-jumps%3A-stock-moves-17-higher-2017-05-22", "https://www.nasdaq.com/articles/vertex-ups-kalydeco-sales-view-as-fda-okays-label-expansion-2017-05-18", "https://www.nasdaq.com/articles/ligand-lgnd-signs-licensing-deal-with-xcella-biosciences-2017-05-31", "https://www.nasdaq.com/articles/reasons-to-add-puma-biotechnology-pbyi-to-portfolio-now-2017-05-17", "https://www.nasdaq.com/articles/alexions-alxn-strensiq-results-positive-in-long-term-study-2017-05-17", "https://www.nasdaq.com/articles/minerva-nerv-provides-phase-iii-development-strategy-for-min-101-2017-05-16", "https://www.nasdaq.com/articles/ionis-ions-stock-falls-despite-positive-inotersen-data-2017-05-16", "https://www.nasdaq.com/articles/mei-pharma-meip-looks-good%3A-stock-adds-5.7-in-session-2016-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-08082016-fatemeipchek-2016-08-08", "https://www.nasdaq.com/articles/health-care-sector-update-08082016-ptimeipchek-2016-08-08", "https://www.nasdaq.com/articles/kamada-kmda-posts-q1-loss-wider-than-expected-sales-miss-2017-05-17", "https://www.nasdaq.com/articles/reasons-to-add-puma-biotechnology-pbyi-to-portfolio-now-2017-05-17", "https://www.nasdaq.com/articles/alexions-alxn-strensiq-results-positive-in-long-term-study-2017-05-17", "https://www.nasdaq.com/articles/minerva-nerv-provides-phase-iii-development-strategy-for-min-101-2017-05-16", "https://www.nasdaq.com/articles/ionis-ions-stock-falls-despite-positive-inotersen-data-2017-05-16", "https://www.nasdaq.com/articles/will-edwards-lifesciences-ew-top-q1-earnings-estimates-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-mei-pharma-meip-tale-of-the-tape-2015-04-21", "https://www.nasdaq.com/articles/will-mead-johnsons-mjn-q1-earnings-surprise-estimates-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/mei-pharma-meip-in-focus%3A-stock-rises-7.9-in-session-2016-04-12", "https://www.nasdaq.com/articles/will-conmed-cnmd-disappoint-earnings-estimates-in-q1-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/will-intuitive-surgical-isrg-surprise-earnings-in-q1-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/can-illumina-ilmn-keep-the-earnings-streak-alive-in-q1-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/mei-pharma-meip-is-in-oversold-territory%3A-whats-next-tale-of-the-tape-2015-04-02", "https://www.nasdaq.com/articles/monday-sector-laggards-railroads-drugs-2015-03-23", "https://www.nasdaq.com/articles/friday-123-insider-buying-report-cprx-meip-2015-01-23", "https://www.nasdaq.com/articles/health-care-sector-update-12232014-achn-meip-abbv-2014-12-23", "https://www.nasdaq.com/articles/resmed-rmd-poised-to-outshine-q3-earnings-estimates-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-mixed-mei-pharma-climbing-after-new-leukemia-drug-produces", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-10-0", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-mei-pharma-meip-tale-of-the-tape-2014-06-02", "https://www.nasdaq.com/articles/mei-pharma-inc.-meip-in-focus%3A-stock-up-12.1-tale-of-the-tape-2014-03-28", "https://www.nasdaq.com/articles/mei-pharma-meip-is-overbought-whats-next-tale-of-the-tape-2014-03-06", "https://www.nasdaq.com/articles/mei-pharma-boosts-oncology-pipeline-analyst-blog-2013-09-11", "https://www.nasdaq.com/articles/topline-data-on-astex-candidate-analyst-blog-2013-08-29", "https://www.nasdaq.com/articles/health-care-sector-update-12122014-sny-meip-onty-2014-12-12"], "Content": []}